Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians
Jean Terrier, Frédéric Gaspar, Pierre Fontana, et al.
The American Journal of Medicine (2021) Vol. 134, Iss. 8, pp. 939-942
Open Access | Times Cited: 16

Showing 16 citing articles:

Drug Interactions Affecting Oral Anticoagulant Use
Philip L. Mar, Rakesh Gopinathannair, Brooke Gengler, et al.
Circulation Arrhythmia and Electrophysiology (2022) Vol. 15, Iss. 6
Open Access | Times Cited: 49
Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: Physicochemical, pharmacokinetic, and DFT-based approaches
Imad Ahmad, Aleksey E. Kuznetsov, Abdul Saboor Pirzada, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 38
Physicochemical properties, drug likeness, ADMET, DFT studies, and in vitro antioxidant activity of oxindole derivatives
Imad Ahmad, Haroon Khan, Goncagül Serdaroğlu
Computational Biology and Chemistry (2023) Vol. 104, pp. 107861-107861
Closed Access | Times Cited: 27
Drug Interactions Affecting Antiarrhythmic Drug Use
Philip L. Mar, Piotr J. Horbal, Mina K. Chung, et al.
Circulation Arrhythmia and Electrophysiology (2022) Vol. 15, Iss. 5
Open Access | Times Cited: 28
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting
Camille Lenoir, Jean Terrier, Yvonne Gloor, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 526-526
Open Access | Times Cited: 20
Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)
Nikolaos Tsoukalas, Norman Brito-Dellan, Carme Font, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 10, pp. 8559-8573
Open Access | Times Cited: 19
Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland
Claire Coumau, Frédéric Gaspar, Jean Terrier, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Physiologically-based pharmacokinetic modeling to predict drug-drug interactions of dabigatran etexilate and rivaroxaban in the Chinese older adults
Jie En Valerie Sia, Xuan Lai, Xinyi Wu, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 182, pp. 106376-106376
Open Access | Times Cited: 8
Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study
Frédéric Gaspar, Jean Terrier, Samantha Favre, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 10, pp. 1541-1552
Open Access | Times Cited: 4
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID‐19 Patients: A Physiologically Based Pharmacokinetic Modeling Study
Jean Terrier, Kenza Abouir, Frédéric Gaspar, et al.
Clinical Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 1
In vitro-in silico pharmacology and chemistry of Stercularin, isolated from Sterculia diversifolia
Imad Ahmad, Fazle Rabbi, Amna Nisar, et al.
Computational Biology and Chemistry (2023) Vol. 109, pp. 108008-108008
Closed Access | Times Cited: 3
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy
Yiyi Ma, Zaiwei Song, Xinya Li, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 3, pp. 279-291
Closed Access
Drug Interactions of Antiarrhythmic Drugs
Ricardo Caballero, Eva Delpón, Juan Tamargo
(2024), pp. 311-341
Closed Access
Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis
L Fedina, I. N. Sychev, T. D. Rastvorova, et al.
Rational Pharmacotherapy in Cardiology (2023) Vol. 18, Iss. 6, pp. 624-629
Open Access | Times Cited: 1
Prediction and Implications of Edoxaban-Associated Bleeding in Patients after Critical Illness
Ryusei Mikami, Mineji Hayakawa, Shungo Imai, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 860-860
Open Access | Times Cited: 1
Direct oral anticoagulant drugs for the management of venous thromboembolism
Joanne Thanavaro
The Nurse Practitioner (2023) Vol. 48, Iss. 6, pp. 27-35
Closed Access
Page 1

Scroll to top